Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Medullary Thyroid Cancer
Metastatic and unresectable medullary thyroid carcinoma (MTC) is often difficult to treat as it is relatively unresponsive to radiation and conventional chemotherapy. This emphasizes the importance of the development of targeted therapies for advanced MTC. Vandetanib was approved by the US Food and...
Main Authors: | Hari A. Deshpande, Khushboo Sheth, Julie A. Sosa, Sanziana A. Roman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S8305 |
Similar Items
-
Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Medullary Thyroid Cancer
by: H. A. Deshpande, et al.
Published: (2012-10-01) -
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
by: Nils Degrauwe, et al.
Published: (2012-01-01) -
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
by: Nils Degrauwe, et al.
Published: (2012-06-01) -
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
by: Hari Deshpande, et al.
Published: (2011-01-01) -
Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Irritability in Autistic Children
by: Eiji Kirino
Published: (2014-01-01)